
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Membranoproliferative glomerulonephritis cost-effectiveness of therapy
Introduction
Albeit, there is several strategies for treatment of MPGN, each method has its own indications, however, new medications such as monoclonal antibodies (Rituximab) is demonstrating new path for future treatment of MPGN[1]
References
- ↑ Michael Rudnicki (2017). “Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies”. Hindawi, BioMed Research International.
